Regulatory14 May 2026, 11:04 am
Indoco Remedies Clears Malta Medicines Authority Audit
AI Summary
Indoco Remedies Ltd. announced that its manufacturing facility for solid oral dosage form (Unit I) in Baddi has received EU GMP certification from the Malta Medicines Authority after an inspection conducted from January 29, 2026, to February 3, 2026. The certification confirms compliance with Good Manufacturing Practice requirements as per the EC Directive. This approval reflects Indoco's commitment to quality and adherence to global regulatory standards.
Key Highlights
- Indoco Remedies' Baddi facility receives EU GMP certification from Malta Medicines Authority.
- The inspection took place from January 29, 2026, to February 3, 2026.
- The certification confirms compliance with Good Manufacturing Practice requirements.
- The company has 10 manufacturing facilities, 6 for FDFs and 4 for APIs.